Robert S. Kieval Joins MDMA Board of Directors
Print Version 
For Immediate Release
Contact: Mark Leahey
Executive Director, MDMA
(202) 349-7174
Washington, D.C., January 31, 2007 – The Medical Device Manufacturers Association (MDMA) recently welcomed to its Board of Directors Robert S. Kieval, V.M.D., Ph.D., Executive Vice President and Chief Technology Officer of CVRx in Maple Grove, Minnesota.
Kieval stated, “I am honored to serve on the Board of the Medical Device Manufacturers Association. MDMA has played a vital role over the past fifteen years to ensure that the voice of innovative, entrepreneurial companies is represented in Washington.”
“MDMA’s Board of Directors has historically reflected the ideals of the innovative, entrepreneurial companies that comprise our membership, and Rob is no exception,” said Mark Leahey, Executive Director of MDMA. “The association remains committed to achieving the legislative and regulatory changes necessary to ensure the research-based entrepreneurial sector of the medical device industry continues to flourish.”
Nancy Briefs, Chair of the MDMA Board of Directors stated, “We are pleased to welcome Rob Kieval to MDMA's Board. His exceptional business and scientific expertise will be a tremendous asset to the board and the membership.”
Other board members include Wayne Barlow of Wescor, Inc.; Stan Bauman of Immuno-Mycologics, Inc.; Nancy Briefs of SmoothShapes, Inc.; Chris Chavez of Advanced Neuromodulation Systems (ANS); Kelvyn Cullimore, Jr. of Dynatronics Corporation; Ryan Drant of New Enterprise Associates; Brad Gary of Allergan, Inc.; Ken Hayes of Radiant Medical, Inc.; Eammon Hobbs of AngioDynamics, Inc.; Joe Kiani of Masimo Corporation; Alex Lukianov of NuVasive, Inc.; Casey McGlynn of Wilson Sonsini Goodrich & Rosati; Guy Nohra of Alta Partners; Jo Ellen Slurzberg of Almyra, Inc.; Thomas Thompson of Neuro Resource Group (NRG); Paul Touhey of Fujirebio Diagnostics, Inc.; Russ Trenary of Advanced Medical Optics (AMO) and Mark Wan of Three Arch Partners.
As a founder of CVRx, Kieval served as its President and CEO between 2001 and 2006, guiding the company’s FDA clinical trial process for its flagship product, the Rheos Barorefelx Hypertension Therapy System. He also raised substantial private equity financing. In 2006, Kieval was named an Innovator of the Year by Twin Cities Finance and Commerce. Kieval earned his bachelor of arts from the University of Pennsylvania, where he later earned his doctorate of physiology and doctorate of veterinary medicine. Kieval has been involved in the medical device industry for 14 years and holds
nineteen U.S. patents.
###
The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, D.C. that represents and serves the innovators and entrepreneurs in the medical device industry. MDMA seeks to improve the quality of patient care by encouraging the development of new medical technology and fostering the availability of innovative products in the marketplace.